PAX5-driven Subtypes of B-progenitor Acute Lymphoblastic Leukemia

Recent genomic studies have identified chromosomal rearrangements defining new subtypes of B-progenitor acute lymphoblastic leukemia (B-ALL), however many cases lack a known initiating genetic alteration. Using integrated genomic analysis of 1,988 childhood and adult cases, we describe a revised taxonomy of B-ALL incorporating 23 subtypes defined by chromosomal rearrangements, sequence mutations or heterogeneous genomic alterations, many of which show marked variation in prevalence according to age. Two subtypes have frequent alterations of the B lymphoid transcription-factor gene PAX5. One, PAX5alt (7.4%), has diverse PAX5 alterations (rearrangements, intragenic amplifications or mutations); a second subtype is defined by PAX5 p.Pro80Arg and biallelic PAX5 alterations. We show that p.Pro80Arg impairs B lymphoid development and promotes the development of B-ALL with biallelic Pax5 alteration in vivo. These results demonstrate the utility of transcriptome sequencing to classify B-ALL and reinforce the central role of PAX5 as a checkpoint in B lymphoid maturation and leukemogenesis.

Citing Articles

Immune training enhances anti-viral responses and improves outcomes in Pax5 mice susceptible to chronic infection.

Lu Z, Stencel O, Liu W, Vasileiou E, Xu H, Pandey P EMBO Mol Med. 2025; .

PMID: 40082582 DOI: 10.1038/s44321-025-00208-4.

Antibody-Based and Other Novel Agents in Adult B-Cell Acute Lymphoblastic Leukemia.

Csizmar C, Litzow M, Saliba A Cancers (Basel). 2025; 17(5).

PMID: 40075627 PMC: 11899621. DOI: 10.3390/cancers17050779.

Application of Omics Analyses in Pediatric B-Cell Acute Lymphoblastic Leukemia.

Vllahu M, Savarese M, Cantiello I, Munno C, Sarcina R, Stellato P Biomedicines. 2025; 13(2).

PMID: 40002837 PMC: 11852417. DOI: 10.3390/biomedicines13020424.

A novel stroma-dependent leukemia cell line from a patient with mixed-phenotype acute leukemia with Ph chromosome and PAX5 mutation.

Ishii S, Arakawa Y, Ishii H, Yokoyama K, Yokoyama H, Saito T Int J Hematol. 2025; .

PMID: 39979768 DOI: 10.1007/s12185-025-03944-y.

Uridine Metabolism as a Targetable Metabolic Achilles' Heel for chemo-resistant B-ALL.

Liu Y, Jiang H, Liu J, Stuani L, Merchant M, Jager A bioRxiv. 2025; .

PMID: 39975156 PMC: 11838334. DOI: 10.1101/2025.01.27.635108.

References

Hardy R, Hayakawa K . B cell development pathways. Annu Rev Immunol. 2001; 19:595-621. DOI: 10.1146/annurev.immunol.19.1.595. View

Tibshirani R, Hastie T, Narasimhan B, Chu G . Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci U S A. 2002; 99(10):6567-72. PMC: 124443. DOI: 10.1073/pnas.082099299. View

Thomas D, Faderl S, Cortes J, OBrien S, Giles F, Kornblau S . Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate. Blood. 2003; 103(12):4396-407. DOI: 10.1182/blood-2003-08-2958. View

Adams B, Dorfler P, Aguzzi A, Kozmik Z, Urbanek P, Busslinger M . Pax-5 encodes the transcription factor BSAP and is expressed in B lymphocytes, the developing CNS, and adult testis. Genes Dev. 1992; 6(9):1589-607. DOI: 10.1101/gad.6.9.1589. View

Kantarjian H, Thomas D, OBrien S, Cortes J, Giles F, Jeha S . Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia. Cancer. 2004; 101(12):2788-801. DOI: 10.1002/cncr.20668. View

Subramanian A, Tamayo P, Mootha V, Mukherjee S, Ebert B, Gillette M . Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005; 102(43):15545-50. PMC: 1239896. DOI: 10.1073/pnas.0506580102. View

Lauberth S, Rauchman M . A conserved 12-amino acid motif in Sall1 recruits the nucleosome remodeling and deacetylase corepressor complex. J Biol Chem. 2006; 281(33):23922-31. DOI: 10.1074/jbc.M513461200. View

Mullighan C, Goorha S, Radtke I, Miller C, Coustan-Smith E, Dalton J . Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature. 2007; 446(7137):758-64. DOI: 10.1038/nature05690. View

Kuiper R, Schoenmakers E, van Reijmersdal S, Hehir-Kwa J, Geurts van Kessel A, van Leeuwen F . High-resolution genomic profiling of childhood ALL reveals novel recurrent genetic lesions affecting pathways involved in lymphocyte differentiation and cell cycle progression. Leukemia. 2007; 21(6):1258-66. DOI: 10.1038/sj.leu.2404691. View

10.

Schebesta A, McManus S, Salvagiotto G, Delogu A, Busslinger G, Busslinger M . Transcription factor Pax5 activates the chromatin of key genes involved in B cell signaling, adhesion, migration, and immune function. Immunity. 2007; 27(1):49-63. DOI: 10.1016/j.immuni.2007.05.019. View

11.

Wang K, Li M, Hadley D, Liu R, Glessner J, Grant S . PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. Genome Res. 2007; 17(11):1665-74. PMC: 2045149. DOI: 10.1101/gr.6861907. View

12.

Goldstone A, Richards S, Lazarus H, Tallman M, Buck G, Fielding A . In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional.... Blood. 2007; 111(4):1827-33. DOI: 10.1182/blood-2007-10-116582. View

13.

Pounds S, Cheng C, Mullighan C, Raimondi S, Shurtleff S, Downing J . Reference alignment of SNP microarray signals for copy number analysis of tumors. Bioinformatics. 2008; 25(3):315-21. PMC: 2639073. DOI: 10.1093/bioinformatics/btn624. View

14.

Mullighan C, Su X, Zhang J, Radtke I, Phillips L, Miller C . Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N Engl J Med. 2009; 360(5):470-80. PMC: 2674612. DOI: 10.1056/NEJMoa0808253. View

15.

den Boer M, van Slegtenhorst M, de Menezes R, Cheok M, Buijs-Gladdines J, Peters S . A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study. Lancet Oncol. 2009; 10(2):125-34. PMC: 2707020. DOI: 10.1016/S1470-2045(08)70339-5. View

16.

Li H, Durbin R . Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009; 25(14):1754-60. PMC: 2705234. DOI: 10.1093/bioinformatics/btp324. View

17.

Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N . The Sequence Alignment/Map format and SAMtools. Bioinformatics. 2009; 25(16):2078-9. PMC: 2723002. DOI: 10.1093/bioinformatics/btp352. View

18.

Pui C, Campana D, Pei D, Bowman W, Sandlund J, Kaste S . Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med. 2009; 360(26):2730-41. PMC: 2754320. DOI: 10.1056/NEJMoa0900386. View

19.

Johnson N, Savage K, Ludkovski O, Ben-Neriah S, Woods R, Steidl C . Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival. Blood. 2009; 114(11):2273-9. PMC: 2745846. DOI: 10.1182/blood-2009-03-212191. View

20.

Ravandi F, OBrien S, Thomas D, Faderl S, Jones D, Garris R . First report of phase 2 study of dasatinib with hyper-CVAD for the frontline treatment of patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia. Blood. 2010; 116(12):2070-7. PMC: 4081177. DOI: 10.1182/blood-2009-12-261586. View